Lymph node ratio is a reliable prognostic marker after neoadjuvant therapy and pancreaticoduodenectomy for pancreatic cancer, but does not predict the utility of adjuvant therapy. (2021) - Adams, A.; McCarthy, P.; O'Shea, A.; Bader, J.; Clifton, G.; Peoples, G.; Nelson, D.; Vreeland, T.